|
Press Release
Vectors
Redwood City, Calif. September 2005— Panomics, Inc. introduces Vectors which are mammalian expression vectors for 74 kinases ready to transfect into cells for gene expression study.
About Panomics, Inc.
Panomics is a privately-held life science company focused on parallel quantitative biology (PQB) a platform of reagents and products that enable the multiplex measurement of molecular events, such as intracellular pathway analysis, cell signaling and gene expression profiling, in a quantitative and scalable manner. Panomics has grown rapidly on the value of QuantiGene and QuantiGene Plex, our proprietary bDNA technology for gene expression analysis in cell-based assays, as well as our signal transduction and transcription factor assays. The company recently launched Deliver X a new siRNA delivery reagent for non-cytotoxic transfection of RNAi reagents into primary cell lines, the first in a series of biomolecule delivery products. Panomics (formerly Genospectra) was founded in 2000 and is based in Fremont, CA. For further information, log on to www.panomics.com. |
